The effect of Heilichrysum pseudoplicatum-syrupe on clinical manifestations of patients with COVID-19

Phase 3

• Conditions: Patients with Corona Virus.; COVID-19, virus identified; U07.1

• Registration Number: IRCT20180610040049N6
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Having informed consent to participate in the study
The definitive diagnosis of COVID-19
Failure to attend another clinical trial simultaneously

Exclusion Criteria

Patient's willingness to use other therapies
Alzheimer's patients

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fatigue. Timepoint: One day before the intervention and 2 weeks after the intervention is measured. Method of measurement: Using a fatigue questionnaire.;Anorexia. Timepoint: One day before the intervention and 2 weeks after the intervention is measured. Method of measurement: Using anorexia questionnaire.;Oxygen saturation. Timepoint: One day before the intervention and 2 weeks after the intervention is measured. Method of measurement: Using a pulse oximeter.;Blood pressure. Timepoint: One day before the intervention and 2 weeks after the intervention is measured. Method of measurement: Using a sphygmomanometer.